Oculo-Cutaneous Albinism Type 4 (OCA4): Phenotype-Genotype Correlation.

OCA4 SLC45A2 foveal hypoplasia genetics hypopigmentation oculo-cutaneous albinism

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
23 11 2022
Historique:
received: 02 10 2022
revised: 04 11 2022
accepted: 15 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Albinism is a genetic disorder, present worldwide, caused by mutations in genes affecting melanin production or transport in the skin, hair and eyes. To date, mutations in at least 20 different genes have been identified. Oculo-cutaneous Albinism type IV (OCA4) is the most frequent form in Asia but has been reported in all populations, including Europeans. Little is known about the genotype-phenotype correlation. We identified two main phenotypes via the analysis of 30 OCA4 patients with a molecularly proven diagnosis. The first, found in 20 patients, is clinically indistinguishable from the classical OCA1 phenotype. The genotype-to-phenotype correlation suggests that this phenotype is associated with homozygous or compound heterozygous nonsense or deletion variants with frameshift leading to translation interruption in the

Identifiants

pubmed: 36553465
pii: genes13122198
doi: 10.3390/genes13122198
pmc: PMC9777904
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pigment Cell Melanoma Res. 2018 Mar;31(2):318-329
pubmed: 28976636
Sci Rep. 2017 Mar 07;7:44185
pubmed: 28266639
Hum Mutat. 2004 Feb;23(2):106-110
pubmed: 14722913
Presse Med. 2017 Jul - Aug;46(7-8 Pt 1):648-654
pubmed: 28734636
Pigment Cell Melanoma Res. 2019 Sep;32(5):672-686
pubmed: 31077556
Am J Hum Genet. 2004 Mar;74(3):466-71
pubmed: 14961451
Orphanet J Rare Dis. 2007 Nov 02;2:43
pubmed: 17980020
Hum Genet. 2022 Sep 27;:
pubmed: 36166100
Pigment Cell Melanoma Res. 2008 Oct;21(5):583-7
pubmed: 18821858
Sci Rep. 2021 Jun 2;11(1):11572
pubmed: 34078970
J Invest Dermatol. 2022 Oct;142(10):2744-2755.e9
pubmed: 35469906
Pigment Cell Melanoma Res. 2018 Jul;31(4):466-474
pubmed: 29345414
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1449-1459
pubmed: 34042219

Auteurs

Ester Moreno-Artero (E)

Department of Dermatology, and Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Université Paris Descartes-Paris Cité, INSERM U1163, Institut Imagine, APHP, Hôpital Universitaire Necker-Enfants Malades, 75015 Paris, France.

Fanny Morice-Picard (F)

Department of Dermatology, Reference Centre for Genodermatoses and Rare Skin Diseases, INSERM U1312, Bordeaux University Hospital, 33000 Bordeaux, France.

Eulalie Lasseaux (E)

Department of Medical Genetics, Bordeaux University Hospital, 33000 Bordeaux, France.

Matthieu P Robert (MP)

Department of Ophthalmology, and Reference Center for Rare Eye Diseases (OPHTARA), Université Paris Cité, Hôpital Universitaire Necker-Enfants Malades, APHP, 75015 Paris, France.
Borelli Centre, UMR 9010, CNRS-SSA-ENS Paris Saclay-Université Paris Cité, 91190 Paris, France.

Valentine Coste (V)

Department of Ophthalmology, Bordeaux University Hospital, 33000 Bordeaux, France.

Vincent Michaud (V)

Department of Medical Genetics, Bordeaux University Hospital, 33000 Bordeaux, France.
INSERM U1211, Laboratory for Rare Diseases, Genetics and Metabolism, 33000 Bordeaux, France.

Stéphanie Leclerc-Mercier (S)

Department of Pathology, and Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Université Paris Descartes-Paris Cité, APHP, Hôpital Universitaire Necker-Enfants Malades, 75015 Paris, France.

Dominique Bremond-Gignac (D)

Department of Ophthalmology, and Reference Center for Rare Eye Diseases (OPHTARA), Université Paris Cité, Hôpital Universitaire Necker-Enfants Malades, APHP, 75015 Paris, France.
INSERM, UMRS 1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Université Paris Descartes-Paris Cité, 75015 Paris, France.

Benoit Arveiler (B)

Department of Medical Genetics, Bordeaux University Hospital, 33000 Bordeaux, France.
INSERM U1211, Laboratory for Rare Diseases, Genetics and Metabolism, 33000 Bordeaux, France.

Smail Hadj-Rabia (S)

Department of Dermatology, and Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Université Paris Descartes-Paris Cité, INSERM U1163, Institut Imagine, APHP, Hôpital Universitaire Necker-Enfants Malades, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH